New detection assay based on real-time PCR amplification of the N Gene of SARS-CoV-2 and SARS-CoV.
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a beta coronavirus that emerged in Wuhan, China in December 2019. Fever, cough and breathing difficulties are described as the most common symptoms of this novel coronavirus diseases (COVID-19.)
Universal Design: The primer and probe design chosen by ingenetix in ViroReal® Kit SARS-CoV-2 & SARS is not identical with the WHO design. The ingenetix kit is intended to cover possible future changes in the virus sequence, therefore a highly conserved region in all SARS-clusters of the N gene was chosen as target region. This approach allows universal detection of all so far known SARS strains including SARS-CoV-2 without discriminating between strains.
For further information use the links below: